New York Life Investment Management LLC Corcept Therapeutics Inc Transaction History

New York Life Investment Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$21.1 - $27.46 $303,987 - $395,616	14,407 New	14,407 $362,000
Q4 2022 Feb 10, 2023	BUY	$19.95 - $29.96 $53,884 - $80,921	2,701 Added 12.01%	25,188 $511,000
Q3 2022 Nov 10, 2022	BUY	$24.7 - $29.12 $43,941 - $51,804	1,779 Added 8.59%	22,487 $577,000
Q2 2022 Aug 12, 2022	BUY	$17.33 - $25.3 $358,869 - $523,912	20,708 New	20,708 $492,000

355

86.2M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $7.17B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of New York Life Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on New York Life Investment Management LLC with notifications on news.